PitchBook分析师注：药物开发中的人工智能（英）-2025
EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of
报告摘要
EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of
报告信息
- 文件全名
- 《PitchBook分析师注：药物开发中的人工智能（英）-2025-12页.pdf》
- 适合读者
- 核心数据
- services constitute 62.5% of the total deal count, while AI-native drug developers
- have attracted the larger share of the total capital, at 70.1%.
- AI-native biotechs have a nearly 100% valuation premium: In 2024, AI-native
- deal counts up 51.8% on a TTM basis. Startups in the space offer a faster path to
- 核心议题
常见问题
《PitchBook分析师注：药物开发中的人工智能（英）-2025》主要包含哪些内容?
EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of核心数据:services constitute 62.5% of the total deal count, while AI-native drug developers;have attracted the larger share of the total capital, at 70.1%.;AI-native biotechs have a nearly 100% valuation premium: In 2024, AI-native。
这份报告覆盖哪一年、篇幅多大?
覆盖 2025 年,全文共 12 页。
这份报告是免费的吗?如何获取?
本报告免费查阅,登录资料宝后即可在线获取完整内容。
这份报告适合哪些读者?
适合战略规划、行业研究员等读者参考。
报告涉及哪些关键议题?
重点分析了人工智能、AI等议题。
继续阅读
查看全部 →